Lactic Acid Disorers Disorders

Medical Advocates
HIV Infection/Disease

Lactic Acid Alterations/Disorders

Hyperlactatemia
Lactic Acidosis

HIV Metabolic Disorders Main Page

Main New/Newsworthy

Home Page

Last Update: October 11, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

Hyperlactatemia

Journal Papers, Abstracts, and Commentaries

Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults
exposed to antiretroviral therapy.
Lactic Acidosis International Study Group.
AIDS. 2007 Nov 30;21(18):2455-64.
Abstract

A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving
highly active antiretroviral therapy in Soweto, South Africa.
Bolhaar MG, Karstaedt AS.
Clin Infect Dis. 2007 Jul 15;45(2):254-60.
Abstract

Limitation of exercise capacity in nucleoside-treated HIV-infected patients with
hyperlactataemia.
Duong M, Dumas J, Buisson M, et al
HIV Med. 2007 Mar;8(2):105-11.
Abstract

Risk Factors for and Outcome of Hyperlactatemia in HIV-Infected Persons: Is There a Need for
Routine Lactate Monitoring?
Imhof A, Ledergerber B, Gunthard HF, et al
Clin Infect Dis. 2005 Sep 1;41(5):721-8
Abstract

Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral
therapy.
Calza L, Manfredi R, Chiodo F. et al
Clin Nutr. 2005 Feb;24(1):5-15.
Abstract

Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in
HIV-1-infected patients (IMEA015 study).
Lamotte C, Landman R, Peytavin G,et al
Antivir Ther. 2004 Apr;9(2):247-56.
Abstract

Safety and efficacy of switching to alternative nucleoside analogues following symptomatic
hyperlactatemia and lactic acidosis.
Lonergan JT, Barber RE, Mathews WC.
AIDS. 2003 Nov 21;17(17):2495-9.
Abstract

Matched case-control study to evaluate risk factors for hyperlactataemia in HIV patients on
antiretroviral therapy.
Datta D, Moyle G, Mandalia S, Gazzard B.
HIV Med. 2003 Oct;4(4):311-4
Abstract

Frequency, Risk Factors, and Outcome of Hyperlactatemia in HIV-positive Persons:
Implications for the Management of Treated Patients.
Marceau G, Sapin V, Jacomet C, et al
Clin Chem. 2003 Jul;49(7):1154-62.
Abstract

FULL-TEXT ARTICLE
Prevalence, risk factors and outcome of hyperlactataemia in HIV-infected patients.
Hocqueloux L, Alberti C, Feugeas JP,
HIV Med 2003 Jan;4(1):18-23
Paper

FULL-TEXT ARTICLE
Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.
Antoniou T, Weisdorf T, Gough K.
CMAJ 2003 Jan 21;168(2):195-8
Paper

Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
Vrouenraets SM, Treskes M, Regez RM, et al.
Antivir Ther 2002 Dec;7(4):239-44
Abstract

Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected
patients receiving nucleoside analogue combination regimens.
Lonergan JT, Behling C, Pfander H, et al.
Clin Infect Dis 2000 Jul;31(1):162-6
Abstract

Conference Reports, Abstracts, and Posters
	International Case-control Study of Lactic Acidosis and Severe Hyperlactatemia in Treated HIV-infected Adults A Arenas-Pinto and International Lactic Acidosis Study Group (14 CROI) Abstract

Lactic Acidosis

Journal Papers, Abstracts, and Commentaries

A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly
active antiretroviral therapy in Soweto, South Africa.
Bolhaar MG, Karstaedt AS.
Clin Infect Dis. 2007 Jul 15;45(2):254-60.
Abstract

Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral
therapy.
Calza L, Manfredi R, Chiodo F. et al
Clin Nutr. 2005 Feb;24(1):5-15.
Abstract

Prognostic factors in lactic acidosis syndrome caused by nucleoside reverse transcriptase
inhibitors: report of eight cases and review of the literature.
Tripuraneni NS, Smith PR, Weedon J
Abstract

Bench-to-bedside review: Severe lactic acidosis in HIV patients treated with nucleoside
analogue reverse transcriptase inhibitors.
Claessens YE, Chiche JD, Mira JP, Cariou A.
Crit Care. 2003 Jun;7(3):226-32. Epub 2003 Feb 28.
Abstract

Miller Fisher variant of Guillain-Barre syndrome associated with lactic acidosis and
stavudine therapy.
Shah SS, Rodriguez T, McGowan JP.
Clin Infect Dis. 2003 May 15;36(10):e131-3.
Abstract

Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside
reverse-transcriptase inhibitors: a case-control study.
Bonnet F, Bonarek M, Morlat P, et al
Clin Infect Dis. 2003 May 15;36(10):1324-8.
Abstract

Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral
regimen containing didanosine.
Murphy MD, O'Hearn M, Chou S. et al.
Clin Infect Dis. 2003 Apr 15;36(8):1082-5.
Abstract

Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of |
human immunodeficiency virus-infected patients, and treatment with L-carnitine.
Claessens YE, Cariou A, Monchi M, et al
Crit Care Med. 2003 Apr;31(4):1042-7.
Abstract

Severe lactic acidosis in HIV-infected patients treated with nucleosidic reverse transcriptase
analogs: a report of 9 cases
Bonnet F, Bonarek M, Abridj A, et al.
Rev Med Interne. 2003 Jan;24(1):11-6
Abstract

Report of three cases of hyperlactacidemiae/lactic acidosis after treatment of hepatitis C
with pegylated interferon and ribavirin in HIV coinfected patients
Montes Ramirez ML, Rodriguez Zapata M.
Rev Clin Esp. 2002 Oct;202(10):543-5.
Abstract

Lactic acidosis associated with nucleoside analog therapy in an HIV-positive patient.
Goldfarb-Rumyantzev AS, Jeyakumar A, et al.
AIDS Patient Care STDS 2000 Jul;14(7):339-42
Abstract

Conference Reports, Abstracts, and Posters
	International Case-control Study of Lactic Acidosis and Severe Hyperlactatemia in Treated HIV-infected Adults A Arenas-Pinto and International Lactic Acidosis Study Group (14 CROI) Abstract

HIV Metabolic Disorders Main Page

Main New/Newsworthy

Home Page

Lactic Acid Alterations/Disorders

		Lactic Acid Alterations/Disorders
		Hyperlactatemia Lactic Acidosis